Innate Pharma files its 2020 Universal Registration Document (document d’enregistrement universel) and 2020 Annual Report on Form 20-F
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
Number of Shares and Voting Rights of Innate Pharma as of April 1, 2021
Innate Pharma reports Full Year 2020 financial results and business update
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
Number of shares and voting rights of Innate Pharma as of February 1, 2021
Innate Pharma to participate in the 10th annual SVB Leerink Global Healthcare Conference
Innate Pharma advances lacutamab clinical development program
Innate Pharma to host key opinion leader discussion on the potential role of lacutamab across T-cell lymphomas
Innate's first NK cell engager selected by Sanofi as drug candidate for development
